421 related articles for article (PubMed ID: 28864059)
1. Role of omentin 1 and IL-6 in type 2 diabetes mellitus patients with diabetic nephropathy.
Senthilkumar GP; Anithalekshmi MS; Yasir M; Parameswaran S; Packirisamy RM; Bobby Z
Diabetes Metab Syndr; 2018; 12(1):23-26. PubMed ID: 28864059
[TBL] [Abstract][Full Text] [Related]
2. Assessment of the Diagnostic Utility of Serum Omentin 1 and IL-6 in Early Stages of Diabetic Nephropathy.
Devi S; Sahu S; Behera KK; Sahoo D; Priyadarshini N
J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443364
[TBL] [Abstract][Full Text] [Related]
3. Serum obestatin and omentin levels in patients with diabetic nephropathy.
Zorlu M; Kiskac M; Güler EM; Gültepe I; Yavuz E; Çelik K; Kocyigit A
Niger J Clin Pract; 2017 Feb; 20(2):182-187. PubMed ID: 28091434
[TBL] [Abstract][Full Text] [Related]
4. Serum omentin-1 levels in diabetic and nondiabetic patients with chronic kidney disease.
Tekce H; Tekce BK; Aktas G; Alcelik A; Sengul E
Exp Clin Endocrinol Diabetes; 2014 Sep; 122(8):451-6. PubMed ID: 24918534
[TBL] [Abstract][Full Text] [Related]
5. Changes of serum omentin-1 levels in normal subjects and in patients with impaired glucose regulation and with newly diagnosed and untreated type 2 diabetes.
Pan HY; Guo L; Li Q
Diabetes Res Clin Pract; 2010 Apr; 88(1):29-33. PubMed ID: 20129687
[TBL] [Abstract][Full Text] [Related]
6. Association of serum omentin levels with cardiac autonomic neuropathy in patients with type 2 diabetes mellitus: a hospital-based study.
Jung CH; Jung SH; Kim BY; Kim CH; Kang SK; Mok JO
Cardiovasc Diabetol; 2015 Oct; 14():140. PubMed ID: 26466574
[TBL] [Abstract][Full Text] [Related]
7. The Effects of Blood Glucose Regulation in Omentin-1 Levels among Diabetic Patients.
Arman Y; Kirna K; Ugurlukisi B; Kutlu O; Dikker O; Cil EO; Akarsu M; Ozcan M; Yuruyen G; Demir P; Altun O; Ozsenel EB; Erdem MG; Sandikci R; Tukek T
Exp Clin Endocrinol Diabetes; 2017 Apr; 125(4):262-266. PubMed ID: 28073124
[No Abstract] [Full Text] [Related]
8. Changes of serum omentin-1 levels in normal subjects, type 2 diabetes and type 2 diabetes with overweight and obesity in Chinese adults.
Zhang Q; Zhu L; Zheng M; Fan C; Li Y; Zhang D; He Y; Yang H
Ann Endocrinol (Paris); 2014 Jul; 75(3):171-5. PubMed ID: 24997770
[TBL] [Abstract][Full Text] [Related]
9. Association between omentin levels and insulin resistance in pregnancy.
Aktas G; Alcelik A; Ozlu T; Tosun M; Tekce BK; Savli H; Tekce H; Dikbas O
Exp Clin Endocrinol Diabetes; 2014 Mar; 122(3):163-6. PubMed ID: 24643693
[TBL] [Abstract][Full Text] [Related]
10. Changes of serum omentin levels and relationship between omentin and adiponectin concentrations in type 2 diabetes mellitus.
Yan P; Liu D; Long M; Ren Y; Pang J; Li R
Exp Clin Endocrinol Diabetes; 2011 Apr; 119(4):257-63. PubMed ID: 21374544
[TBL] [Abstract][Full Text] [Related]
11. [Expression of omentin in adipose tissues in obese and type 2 diabetic patients].
Cai RC; Wei L; DI JZ; Yu HY; Bao YQ; Jia WP
Zhonghua Yi Xue Za Zhi; 2009 Feb; 89(6):381-4. PubMed ID: 19567114
[TBL] [Abstract][Full Text] [Related]
12. The correlation of plasma omentin-1 with insulin resistance in non-obese polycystic ovary syndrome.
Yang HY; Ma Y; Lu XH; Liang XH; Suo YJ; Huang ZX; Lu DC; Qin YF; Luo ZJ
Ann Endocrinol (Paris); 2015 Oct; 76(5):620-7. PubMed ID: 26514948
[TBL] [Abstract][Full Text] [Related]
13. Circulating levels of asprosin and its association with insulin resistance and renal function in patients with type 2 diabetes mellitus and diabetic nephropathy.
Goodarzi G; Setayesh L; Fadaei R; Khamseh ME; Aliakbari F; Hosseini J; Moradi N
Mol Biol Rep; 2021 Jul; 48(7):5443-5450. PubMed ID: 34304366
[TBL] [Abstract][Full Text] [Related]
14. Changes in Serum Nampt Levels and Its Significances in Diabetic Nephropathy Patients-The Potential Role of Nampt in T2DM with Diabetic Nephropathy.
Ma X; An L; Wang Q
Endocr Metab Immune Disord Drug Targets; 2017; 17(2):114-124. PubMed ID: 28699485
[TBL] [Abstract][Full Text] [Related]
15. Modulatory Role of Omentin-1 in Inflammation: Cytokines and Dietary Intake.
Zabetian-Targhi F; Mirzaei K; Keshavarz SA; Hossein-Nezhad A
J Am Coll Nutr; 2016; 35(8):670-678. PubMed ID: 27331575
[TBL] [Abstract][Full Text] [Related]
16. Serum omentin-1, inflammation and carotid atherosclerosis in patients with non-diabetic chronic kidney disease.
Sengul E; Duygulu G; Dindar S; Bunul F
Ren Fail; 2013 Sep; 35(8):1089-93. PubMed ID: 23883412
[TBL] [Abstract][Full Text] [Related]
17. Effects of the long-acting human glucagon-like peptide-1 analog liraglutide on plasma omentin-1 levels in patients with type 2 diabetes mellitus.
Yan P; Li L; Yang M; Liu D; Liu H; Boden G; Yang G
Diabetes Res Clin Pract; 2011 Jun; 92(3):368-74. PubMed ID: 21458097
[TBL] [Abstract][Full Text] [Related]
18. Non-Alcoholic Fatty Liver Disease Is a Risk Factor for the Development of Diabetic Nephropathy in Patients with Type 2 Diabetes Mellitus.
Jia G; Di F; Wang Q; Shao J; Gao L; Wang L; Li Q; Li N
PLoS One; 2015; 10(11):e0142808. PubMed ID: 26566287
[TBL] [Abstract][Full Text] [Related]
19. [Correlation of serum omentin-1 and chemerin with gestational diabetes mellitus].
Pan BL; Ma RM
Nan Fang Yi Ke Da Xue Xue Bao; 2016 Aug; 36(9):1231-1236. PubMed ID: 27687656
[TBL] [Abstract][Full Text] [Related]
20. Serum levels of CTRP3 in diabetic nephropathy and its relationship with insulin resistance and kidney function.
Moradi N; Fadaei R; Khamseh ME; Nobakht A; Rezaei MJ; Aliakbary F; Vatannejad A; Hosseini J
PLoS One; 2019; 14(4):e0215617. PubMed ID: 31009504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
